Emergent BioSolutions Inc
LSE:0IGA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Emergent BioSolutions Inc
LSE:0IGA
|
US |
|
Superior Group of Companies Inc
F:6G6
|
US |
Wall St Price Targets
0IGA Price Targets Summary
Emergent BioSolutions Inc
According to Wall Street analysts, the average 1-year price target for 0IGA is 12.39 USD with a low forecast of 12.27 USD and a high forecast of 12.76 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IGA's stock price target?
Price Target
12.39
USD
According to Wall Street analysts, the average 1-year price target for 0IGA is 12.39 USD with a low forecast of 12.27 USD and a high forecast of 12.76 USD.
What is the Revenue forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is 4%.
What is the Gross Profit forecast for Emergent BioSolutions Inc?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 1 year is -9%.
What is the Operating Income forecast for Emergent BioSolutions Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 7 years is 17%.
What is the Net Income forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 1 year is 4%.
